MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Impact of non-pharmacological strategies on progression in Parkinson’s Disease and Cognitive Impairment.

    MAG. Medrano-Delgado, DR. Aguila-Godinez, MF. Ruiz-Mafud, LG. Lira-Juárez, EC. Santiago Delacruz, A. Domínguez-García, AJ. Hernández-Medrano, AY. Regalado-Mustafá, MF. Medina-Pérez, G. Hernandez-Armesto, K. Talavera-Laguna, A. Herrera-Ruiz, J. García-Hernández, DP. Romero-Terán, A. Alcocer-Salas, G. Cerda-Hernández, A. Abundes-Corona, M. Rodríguez-Violante, A. Cervantes-Arriaga (Ciudad de Mexico, Mexico)

    Objective: to determine the Impact of non-pharmacological strategies on progression in Parkinson's Disease and Cognitive Impairment. Background: PD is the second most common neurodegenerative disorder,…
  • 2023 International Congress

    The phenotypic spectrum and assessment of severity in patients of Spinocerebellar Ataxia-12.

    V. Mathur, A. Shetty, P. Wadia (Jaipur, India)

    Objective: To describe clinical phenotype, manifestations, and assess tremor severity using standard rating scale in genetically confirmed patients with SCA12. Background: Spinocerebellar Ataxia-12 (SCA12) occurs…
  • 2023 International Congress

    Generalized dystonia and spasticity: The fault in the mitochondria

    A. Saini, S. Khanna (Chandigarh, India)

    Objective: To analyze the pattern of movement disorder in a child with mitochondrial respiratory chain disorder Background: Secondary movement disorders are often a clue to…
  • 2023 International Congress

    Differences of social and clinical factors related with distribution of DBS in Mexican PD population

    MF. Medina Pérez, DR. Aguila Godinez, AA. Herrera Ruiz, EC. Santiago Cruz, LG. Lira Juárez, MAG. Medrano Delgado, MA. Ruiz Mafud, AJ. Hernández-Medrano, AY. Regalado Mustafá, DP. Romero-Terán, GI. Cerda Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga, G. Hernandez Armesto, A. Abundes-Corona, AG. Alcocer-Salas (Mexico, Mexico)

    Objective: To identify which social and clinical factors are related to disparities between the distribution of DBS in Mexican PD population Background: Deep Brain stimulation…
  • 2023 International Congress

    Clinical toolkits to improve conversations about Parkinson’s dementia

    I. Dobreva, J. Thomas, M. Roche, C. Dore, S. Rose, S. Baldwin-Jones, R. O'Connell, A. Marr, C. Hugill, R. Weil (London, United Kingdom)

    Objective: To co-produce, with people living with Parkinson’s and professionals, a pair of toolkits to improve conversations about Parkinson’s dementia in the clinic: one for…
  • 2023 International Congress

    Correlation between dose of dopamine replacement therapy and King’s Parkinson’s Disease Pain Scale in Mexican Patients with Parkinson’s Disease

    A. Regalado Mustafá, D. Aguila Godinez, A. Herrera Ruiz, E. Santiago-de-La-Cruz, L. Lira Juárez, M. Medrano Delgado, M. Ruiz Mafud, A. Hernández-Medrano, D. Romero-Terán, M. Medina-Pérez, G. Cerda Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga, G. Hernandez Armesto, A. Abundes-Corona, A. Domínguez García, J. García Hernández, A. Alcocer Salas, K. Talavera Lagunas (Mexico City, Mexico)

    Objective: Investigate the relationship between the dose of dopamine replacement therapy (DRT) and pain severity as measured by the King's Parkinson's Disease Pain Scale (KPPS)…
  • 2023 International Congress

    Clinical characterization of patients with functional movement disorders

    Y. Guzman, A. Soto, T. Saldivar (Mexico City, Mexico)

    Objective: To clinically characterize functional movement disorders in a Cuban cohort. Background: Functional movement disorders are those that cannot be explained by an organic disease…
  • 2023 International Congress

    Deep Brain Stimulation for Multiple Sclerosis Tremors: A Case Series

    P. Gyawali, F. Farrokhi, M. Marsans, J. Roberts (Seattle, USA)

    Objective: The objective of our study is to report the evidence on the effectiveness and safety of Deep Brain Stimulation (DBS) in managing upper extremity…
  • 2023 International Congress

    Clinical and radiological characteristics of a cohort of seventy-one Multiple System Atrophy patients

    G. Franco, G. Lazzeri, E. Bernardi, F. Arienti, A. Di Fonzo (Milan, Italy)

    Objective: This study aimed to review the characteristics of large cohort of MSA patients diagnosis in our center, confirming previous clinical and imaging data from…
  • 2023 International Congress

    Impact of the COVID-19 pandemic in the long-term efficacy of botulinum toxin treatment

    F. Barros, C. Nunes, F. Magalhães, A. Mestre, C. Machado, D. Carneiro (Coimbra, Portugal)

    Objective: To analyse the impact of the COVID-19 pandemic in the long-term efficacy of treatment with botulinum toxin (BoT). Background: The COVID-19 pandemic brought new…
  • « Previous Page
  • 1
  • …
  • 498
  • 499
  • 500
  • 501
  • 502
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley